external guide sequence therapeutics (Keren Pharmaceutical)

N/A

Report date: 2025/05/14 13:51:54

Base Information

Drug Nameexternal guide sequence therapeutics (Keren Pharmaceutical)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > mRNASmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionInterleukin-4 receptors inhibitors
TargetsInterleukin-4 receptors
Therapy Area/IndicationsPneumonia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKeren Pharmaceutical Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKeren Pharmaceutical Inc
Active IndicationsN/A
Inactive IndicationsPneumonia

Other Information

ATC CodeN/A
Related LinksN/A